165 related articles for article (PubMed ID: 35278461)
41. MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer.
Liu MX; Zhou KC; Cao Y
Mol Cancer; 2014 Nov; 13():245. PubMed ID: 25373388
[TBL] [Abstract][Full Text] [Related]
42. GRWD1 promotes cell proliferation and migration in non-small cell lung cancer by activating the Notch pathway.
Wang Q; Ren H; Xu Y; Jiang J; Wudu M; Liu Z; Su H; Jiang X; Zhang Y; Zhang B; Qiu X
Exp Cell Res; 2020 Feb; 387(2):111806. PubMed ID: 31891681
[TBL] [Abstract][Full Text] [Related]
43. B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes.
Altan M; Pelekanou V; Schalper KA; Toki M; Gaule P; Syrigos K; Herbst RS; Rimm DL
Clin Cancer Res; 2017 Sep; 23(17):5202-5209. PubMed ID: 28539467
[No Abstract] [Full Text] [Related]
44. Interaction of hnRNP K with MAP 1B-LC1 promotes TGF-β1-mediated epithelial to mesenchymal transition in lung cancer cells.
Li L; Yan S; Zhang H; Zhang M; Huang G; Chen M
BMC Cancer; 2019 Sep; 19(1):894. PubMed ID: 31492158
[TBL] [Abstract][Full Text] [Related]
45. Salinomycin suppresses TGF-β1-induced EMT by down-regulating MMP-2 and MMP-9 via the AMPK/SIRT1 pathway in non-small cell lung cancer.
Hwang KE; Kim HJ; Song IS; Park C; Jung JW; Park DS; Oh SH; Kim YS; Kim HR
Int J Med Sci; 2021; 18(3):715-726. PubMed ID: 33437206
[TBL] [Abstract][Full Text] [Related]
46. ANGPTL4 Correlates with NSCLC Progression and Regulates Epithelial-Mesenchymal Transition via ERK Pathway.
Zhu X; Guo X; Wu S; Wei L
Lung; 2016 Aug; 194(4):637-46. PubMed ID: 27166634
[TBL] [Abstract][Full Text] [Related]
47. Knockdown of TRIM66 inhibits malignant behavior and epithelial-mesenchymal transition in non-small cell lung cancer.
Dai HY; Ma Y; Da Z; Hou XM
Pathol Res Pract; 2018 Aug; 214(8):1130-1135. PubMed ID: 29929749
[TBL] [Abstract][Full Text] [Related]
48. LncRNA NBR2 inhibits EMT progression by regulating Notch1 pathway in NSCLC.
Gao YP; Li Y; Li HJ; Zhao B
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7950-7958. PubMed ID: 31599420
[TBL] [Abstract][Full Text] [Related]
49. Prognostic role of B7-H4 in patients with non-small cell lung cancer: A meta-analysis.
Tan Z; Shen W
Oncotarget; 2017 Apr; 8(16):27137-27144. PubMed ID: 28404927
[TBL] [Abstract][Full Text] [Related]
50. Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.
Wang L; Yang H; Lei Z; Zhao J; Chen Y; Chen P; Li C; Zeng Y; Liu Z; Liu X; Zhang HT
Oncogene; 2016 Feb; 35(7):867-77. PubMed ID: 25961934
[TBL] [Abstract][Full Text] [Related]
51. Long noncoding RNA SNHG7 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition in non-small cell lung cancer by regulating miR-449a/TGIF2 axis.
Pang L; Cheng Y; Zou S; Song J
Thorac Cancer; 2020 Feb; 11(2):264-276. PubMed ID: 31793741
[TBL] [Abstract][Full Text] [Related]
52. Overexpression of integrin-linked kinase correlates with malignant phenotype in non-small cell lung cancer and promotes lung cancer cell invasion and migration via regulating epithelial-mesenchymal transition (EMT)-related genes.
Chen D; Zhang Y; Zhang X; Li J; Han B; Liu S; Wang L; Ling Y; Mao S; Wang X
Acta Histochem; 2013 Mar; 115(2):128-36. PubMed ID: 22683084
[TBL] [Abstract][Full Text] [Related]
53. LncRNA MALAT-1 competitively regulates miR-124 to promote EMT and development of non-small-cell lung cancer.
Wu J; Weng Y; He F; Liang D; Cai L
Anticancer Drugs; 2018 Aug; 29(7):628-636. PubMed ID: 29782349
[TBL] [Abstract][Full Text] [Related]
54. Ethacrynic acid suppresses B7-H4 expression involved in epithelial-mesenchymal transition of lung adenocarcinoma cells via inhibiting STAT3 pathway.
Yu L; Ji Kim H; Kim B; Jung Byun H; Minh Nguyen T; Ji Kim E; Huy Phùng H; Hyeon Kim Y; Rahman M; Yun Jang J; Bae Rho S; Jin Kang G; Lee H; Lee K; Kyung Han H; Kyung Park M; Hoon Lee C
Biochem Pharmacol; 2023 Jun; 212():115537. PubMed ID: 37019184
[TBL] [Abstract][Full Text] [Related]
55. miR-138 suppresses the proliferation, metastasis and autophagy of non-small cell lung cancer by targeting Sirt1.
Ye Z; Fang B; Pan J; Zhang N; Huang J; Xie C; Lou T; Cao Z
Oncol Rep; 2017 Jun; 37(6):3244-3252. PubMed ID: 28498463
[TBL] [Abstract][Full Text] [Related]
56. CNOT4 suppresses nonsmall cell lung cancer progression by promoting the degradation of PAF1.
Zhang B; Zhao B; Han S; Chen S
Mol Carcinog; 2023 Oct; 62(10):1563-1571. PubMed ID: 37493105
[TBL] [Abstract][Full Text] [Related]
57. MiR-30 suppresses lung cancer cell 95D epithelial mesenchymal transition and invasion through targeted regulating Snail.
Fan MJ; Zhong YH; Shen W; Yuan KF; Zhao GH; Zhang Y; Wang SK
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2642-2649. PubMed ID: 28678320
[TBL] [Abstract][Full Text] [Related]
58. B7-H4 is a potential diagnostic and prognostic biomarker in colorectal cancer and correlates with the epithelial-mesenchymal transition.
Yan X; Hong B; Feng J; Jin Y; Chen M; Li F; Qian Y
BMC Cancer; 2022 Oct; 22(1):1053. PubMed ID: 36217128
[TBL] [Abstract][Full Text] [Related]
59. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene.
Li Y; Zhang H; Li Y; Zhao C; Fan Y; Liu J; Li X; Liu H; Chen J
Mol Carcinog; 2018 Jan; 57(1):125-136. PubMed ID: 28940757
[TBL] [Abstract][Full Text] [Related]
60. Krüppel-Like Factor 8 Overexpression Correlates with Poor Prognosis in Non-Small Cell Lung Cancer.
Li J; Liu Y; Xue J; Xu M; Zhang J; Liu J; Wang W
Pathol Oncol Res; 2019 Jan; 25(1):115-121. PubMed ID: 28986741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
